SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 80 filers reported holding SAVARA INC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,155,000 | +11.8% | 1,568,002 | 0.0% | 0.41% | +56.3% |
| Q2 2019 | $3,716,000 | -83.7% | 1,568,002 | -49.3% | 0.26% | -81.7% |
| Q1 2019 | $22,800,000 | -2.6% | 3,093,690 | 0.0% | 1.44% | -16.4% |
| Q4 2018 | $23,419,000 | -32.2% | 3,093,690 | 0.0% | 1.72% | -7.4% |
| Q3 2018 | $34,526,000 | +12.5% | 3,093,690 | +14.1% | 1.86% | -6.1% |
| Q2 2018 | $30,691,000 | +23.0% | 2,711,190 | 0.0% | 1.98% | -13.1% |
| Q1 2018 | $24,943,000 | -39.0% | 2,711,190 | -1.6% | 2.28% | -38.3% |
| Q4 2017 | $40,899,000 | – | 2,756,012 | – | 3.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |